Literature DB >> 36042906

Alkaline phosphatase interference in immuno-enzymatic assays.

Osman Oğuz1, Huriye Serin1, Fatma Sinem Hocaoglu2.   

Abstract

Background: Alkaline phosphatase (ALP) enzymes are widely used as signal amplifiers in immunoenzymatic methods. Conditions that cause ALP elevations, such as bone or liver diseases, can cause interference in immunoenzymatic methods. We aimed to examine ALP's effect on immunoenzymatic assay by adding isolated pure ALP to the prepared serum pool.
Methods: We prepared a serum pool and divided it into 4 groups. By adding isolated pure ALP at different concentrations to each group, we obtained sample groups containing ALP enzyme at concentrations of 85 U/L, 340 U/L, 870 U/L, and 1570 U/L. 20-repetition of bhCG, ferritin, FT4, TSH, troponin I, and Vit B12 tests were performed in each group. The coefficient of variation, bias, and total error was calculated. All groups were compared by using the Friedman test for paired samples.
Results: After ALP addition, the calculated total error values of FT4, bhCG and troponin I tests were above the acceptable error limits. There were statistically significant differences in bhCG, FT4, troponin I, and Vit B12 tests compared to the baseline ALP level (P<0.0125). Conclusions: Isolated ALP elevations can be a source of interference for immunoenzymatic methods. 2022 Osman Oğuz, Huriye Serin, Fatma Sinem Hocaoglu, published by CEON/CEES.

Entities:  

Keywords:  ALP; Alkaline phosphatase; bias; immunoenzymatic; total error

Year:  2022        PMID: 36042906      PMCID: PMC9375535          DOI: 10.5937/jomb0-33981

Source DB:  PubMed          Journal:  J Med Biochem        ISSN: 1452-8266            Impact factor:   2.157


  9 in total

Review 1.  The new era of automated immunoassay.

Authors:  J L Bock
Journal:  Am J Clin Pathol       Date:  2000-05       Impact factor: 2.493

2.  Effect of elevated concentration of alkaline phosphatase on cardiac troponin I assays.

Authors:  A Dasgupta; L Chow; A Wells; P Datta
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

3.  Spurious testosterone laboratory results in a patient taking synthetic alkaline phosphatase (asfotase alfa).

Authors:  Alina G Sofronescu; Meredith Ross; Eric Rush; Whitney Goldner
Journal:  Clin Biochem       Date:  2018-04-27       Impact factor: 3.281

4.  Heterophilic antibodies: a problem for all immunoassays.

Authors:  L M Boscato; M C Stuart
Journal:  Clin Chem       Date:  1988-01       Impact factor: 8.327

5.  Stratus automated creatine kinase-MB assay evaluated: identification and elimination of falsely increased results associated with a high-molecular-mass form of alkaline phosphatase.

Authors:  A W Butch; T T Goodnow; W S Brown; A McClellan; G Kessler; M G Scott
Journal:  Clin Chem       Date:  1989-10       Impact factor: 8.327

6.  Endogenous alkaline phosphatase interference in cardiac troponin I and other sensitive chemiluminescence immunoassays that use alkaline phosphatase activity for signal amplification.

Authors:  Daniel S Herman; Pratistha Ranjitkar; Diane Yamaguchi; David G Grenache; Dina N Greene
Journal:  Clin Biochem       Date:  2016-06-16       Impact factor: 3.281

7.  Alkaline Phosphatases : Structure, substrate specificity and functional relatedness to other members of a large superfamily of enzymes.

Authors:  José Luis Millán
Journal:  Purinergic Signal       Date:  2006-06-17       Impact factor: 3.765

8.  False Positive Troponin I Rendering Two Admissions for "Recurrent Acute Myopericarditis".

Authors:  Rita Marinheiro; Pedro Amador; Leonor Parreira; Quitéria Rato; Rui Caria
Journal:  Open Cardiovasc Med J       Date:  2018-06-29

9.  Detection and characterization of estradiol (E2) and unconjugated estriol (uE3) immunoassay interference due to anti-bovine alkaline phosphatase (ALP) antibodies.

Authors:  Anu S Maharjan; Sara P Wyness; Julie A Ray; Tanya L Willcox; Jonathan D Seiter; Jonathan R Genzen
Journal:  Pract Lab Med       Date:  2019-08-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.